Resumen de acción DGX
Quest Diagnostics Incorporated ofrece pruebas y servicios de diagnóstico en Estados Unidos y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Recompensas
Análisis de riesgos
Competidores de Quest Diagnostics Incorporated
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$138.83 |
| 52 Week High | US$145.62 |
| 52 Week Low | US$119.59 |
| Beta | 0.89 |
| 1 Month Change | -1.39% |
| 3 Month Change | 9.21% |
| 1 Year Change | 1.89% |
| 3 Year Change | 8.92% |
| 5 Year Change | 36.21% |
| Change since IPO | 3,866.57% |
Noticias y actualizaciones recientes
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14
Quest Diagnostics: Let's Keep Waiting
May 08Recent updates
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04Quest Diagnostics declares $0.66 dividend
Nov 14Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 06Decode Health, Quest to collaborate to improve biomarker discovery for drug discovery
Oct 18Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Oct 06Quest Diagnostics to acquire select assets of Summa Health
Oct 05Rentabilidad de los accionistas
| DGX | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | -2.7% | -1.5% | 1.0% |
| 1Y | 1.9% | 6.2% | 21.8% |
Rentabilidad vs. Industria: DGX igualó a la industria US Healthcare, que obtuvo un rendimiento del 0.9% el año pasado.
Rentabilidad vs. Mercado: DGX obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| DGX volatility | |
|---|---|
| DGX Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: DGX no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de DGX (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1967 | 44,000 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated ofrece pruebas y servicios de diagnóstico en Estados Unidos y a escala internacional. La empresa desarrolla y presta servicios de información diagnóstica, como pruebas clínicas rutinarias, no rutinarias y avanzadas, pruebas de anatomía patológica y otros servicios de información diagnóstica. Ofrece servicios de información diagnóstica principalmente bajo la marca Quest Diagnostics, así como bajo las marcas AmeriPath, Dermpath Diagnostics, ExamOne y Quanum a médicos, hospitales, pacientes y consumidores, planes de salud, agencias gubernamentales, empleadores, minoristas, compañías farmacéuticas y aseguradoras, y organizaciones de atención responsable a través de una red de laboratorios, centros de servicio al paciente, flebotomistas en consultorios médicos, centros de llamadas y flebotomistas móviles, enfermeras y otros profesionales de la salud y el bienestar.
Resumen de fundamentos de Quest Diagnostics Incorporated
| Estadísticas fundamentales de DGX | |
|---|---|
| Capitalización bursátil | US$15.64b |
| Beneficios(TTM) | US$842.00m |
| Ingresos (TTM) | US$9.29b |
18.3x
Ratio precio-beneficio (PE)1.7x
Ratio precio-ventas (PS)¿Está DGX sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DGX | |
|---|---|
| Ingresos | US$9.29b |
| Coste de los ingresos | US$6.22b |
| Beneficio bruto | US$3.07b |
| Otros gastos | US$2.23b |
| Beneficios | US$842.00m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 7.58 |
| Margen bruto | 33.08% |
| Margen de beneficio neto | 9.07% |
| Ratio deuda/patrimonio | 72.0% |
¿Cómo se ha desempeñado DGX a largo plazo?
Ver rendimiento histórico y comparativaDividendos
2.2%
Rentabilidad actual por dividendo38%
Ratio de pagos¿Paga DGX dividendos fiables?
Ver historial de dividendos e índices de referencia de DGX| fechas de dividendos de Quest Diagnostics | |
|---|---|
| Fecha ex dividendo | Jul 08 2024 |
| Fecha de pago de dividendos | Jul 22 2024 |
| Días hasta ex dividendo | 25 days |
| Días hasta la fecha de pago de dividendos | 39 days |
¿Paga DGX dividendos fiables?
Ver historial de dividendos e índices de referencia de DGX